{"id":4095,"date":"2024-12-12T02:16:26","date_gmt":"2024-12-12T07:16:26","guid":{"rendered":"https:\/\/citystuff.com\/miami\/?p=4095"},"modified":"2024-12-12T02:16:26","modified_gmt":"2024-12-12T07:16:26","slug":"who-gets-obesity-drugs-covered-by-insurance","status":"publish","type":"post","link":"https:\/\/citystuff.com\/miami\/2024\/12\/12\/who-gets-obesity-drugs-covered-by-insurance\/","title":{"rendered":"Who gets obesity drugs covered by insurance?"},"content":{"rendered":"

The Battle to Cover Obesity Medications: A State-by-State Affair<\/strong><\/p>\n

A Weighty Decision<\/strong><\/p>\n

After years of struggling with weight loss, Anita Blanchard, a University of North Carolina-Charlotte professor, found relief with Ozempic, a medication initially designed to treat Type 2 diabetes. The state employee’s health insurance initially covered the prescription, but after the state employee health plan eliminated coverage for weight loss, Blanchard was forced to pay $225 a month for a non-brand version of the medication.<\/p>\n

The Cost Conundrum<\/strong><\/p>\n

The controversy surrounding Ozempic and other glucagon-like peptide-1 (GPL-1) agonist medications has left many in a lurch. These medications have proven effective for weight loss and Type 2 diabetes management, but the high cost has raised concerns about who should have access to them. The state of North Carolina faced a dilemma when the state employee health plan, which covers over 76,000 employees and their dependents, saw costs skyrocket to $170 million this year, projected to reach over $1 billion in six years.<\/p>\n

A Twist of Fate<\/strong><\/p>\n

In a surprising turn of events, the North Carolina Medicaid program, which covers over 2 million people, began covering the medications for weight loss, not just diabetes. This decision has sparked a debate about who should have access to these medications and how to balance the cost.<\/p>\n

A National Proposal<\/strong><\/p>\n

The Biden administration has proposed covering these medications for Medicaid patients nationwide, in addition to Medicare patients. This proposal has raised concerns about the cost, estimated to be $40 billion over 10 years, including an additional $3.8 billion for states.<\/p>\n

State-by-State Decisions<\/strong><\/p>\n

Other states, such as West Virginia and Connecticut, have taken different approaches. West Virginia canceled its pilot program to cover the drugs for state employees, while Connecticut state employees who are prescribed the drugs must participate in a clinical lifestyle management program.<\/p>\n

The Implications<\/strong><\/p>\n

The ongoing debate highlights concerns about the cost of these medications and the need for a more comprehensive approach to addressing obesity. As Dr. Nishant Shah, a Duke University cardiologist and researcher, noted, "Making these drugs available through Medicaid is in the state’s long-term financial interest."<\/p>\n

Conclusion<\/strong><\/p>\n

The battle to cover obesity medications is a complex and contentious issue, with no easy answers. As the debate continues, one thing is clear: the high cost of these medications has left many struggling to access the treatment they need. It is crucial that policymakers, healthcare providers, and patients work together to find a solution that balances cost with access to life-changing medications.<\/p>\n

FAQs<\/strong><\/p>\n

Q: What are GPL-1 agonist medications?
\nA: GPL-1 agonist medications, such as Ozempic, Trulicity, and Wegovy, are a class of medications used to treat Type 2 diabetes and promote weight loss.<\/p>\n

Q: Why are these medications so expensive?
\nA: The high cost of these medications is due to the expensive manufacturing process and the need for patients to stay on the medications long-term to maintain weight loss.<\/p>\n

Q: Why is there a bias against covering these medications for weight loss?
\nA: Some argue that the bias stems from the perception that obesity is a personal choice, rather than a chronic disease.<\/p>\n

Q: What are the long-term benefits of these medications?
\nA: In addition to weight loss, these medications have been shown to reduce the risk of cardiovascular problems, such as heart attacks and strokes.<\/p>\n","protected":false},"excerpt":{"rendered":"

The Battle to Cover Obesity Medications: A State-by-State Affair A Weighty Decision After years of struggling with weight loss, Anita Blanchard, a University of North Carolina-Charlotte professor, found relief with Ozempic, a medication initially designed to treat Type 2 diabetes. The state employee’s health insurance initially covered the prescription, but after the state employee health […]<\/p>\n","protected":false},"author":4,"featured_media":4096,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rank_math_lock_modified_date":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[22],"tags":[],"class_list":{"0":"post-4095","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-health-wellness"},"jetpack_featured_media_url":"https:\/\/i0.wp.com\/www.sun-sentinel.com\/wp-content\/uploads\/2024\/12\/202412080400MCT_____PHOTO____US-NEWS-HEALTH-NC-OBESITY-DRUGS-MEDICAID-GET-1.jpg?w=1024&h=684&w=1024&resize=1024,683&ssl=1","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/citystuff.com\/miami\/wp-json\/wp\/v2\/posts\/4095"}],"collection":[{"href":"https:\/\/citystuff.com\/miami\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/citystuff.com\/miami\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/citystuff.com\/miami\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/citystuff.com\/miami\/wp-json\/wp\/v2\/comments?post=4095"}],"version-history":[{"count":1,"href":"https:\/\/citystuff.com\/miami\/wp-json\/wp\/v2\/posts\/4095\/revisions"}],"predecessor-version":[{"id":4097,"href":"https:\/\/citystuff.com\/miami\/wp-json\/wp\/v2\/posts\/4095\/revisions\/4097"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/citystuff.com\/miami\/wp-json\/wp\/v2\/media\/4096"}],"wp:attachment":[{"href":"https:\/\/citystuff.com\/miami\/wp-json\/wp\/v2\/media?parent=4095"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/citystuff.com\/miami\/wp-json\/wp\/v2\/categories?post=4095"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/citystuff.com\/miami\/wp-json\/wp\/v2\/tags?post=4095"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}